AesyBite Active demonstrated a statistically significant reduction in bruxism activity and improved orofacial pain in a study of 26 patients, supporting Aesyra’s push for FDA approval in 2026.
Whether sleep bruxism is primary or secondary has implications on disorder management.
Nine hundred patients meeting International Restless Legs Syndrome Study Group criteria for RLS were examined and treated by the author between 2004 and 2014. Of full respondents, up to 51% had the full triad of RLS, migraine headaches, and bruxism. When treated with dopamine agonists, 80% responded for symptoms of RLS and up to 70% for RLS-related bruxism.
Read MoreIn a Dentistry iQ report, Elizabeth Kornegay, RDH, BSDH, focuses on the connection between sleep apnea and bruxism as they relate to predicting first-onset temporomandibular disorders.
Read More
The Weill Cornell Center for Sleep Medicine seeks to advance sleep medicine through comprehensive care, quality processes, and intense research.
Read MoreAccording to new research presented at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, the majority of US dental schools have not adequately prepared their graduates to screen for sleep disorders. Researchers from th
Read More
As we age, our sleep changes and, for many, this can lead to problems.
Read More
Sleep Review interviews Ken Godish, vice president and general manager of SLP; Richard A. Bonato, PhD, president and COO, and Michael R. Clark, director of marketing and sales for BRAEBON Corp; and Ron Fligge, RRT, global product manager, Sleep Diagnostics, at Respironics.
Read More
A Web guide to pertinent products and services.
Read MoreEffective therapeutic intervention is available through behavioral strategies and pharmacotherapy when treating restless legs syndrome and periodic leg movements in sleep
Read More